F. Mahmoudi

Progression-related outcomes of teriflunomide in multiple sclerosis clinical trials

Introduction Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system that leads to neurological disability, more pronounced in the progressive phase. Teriflunomide, an oral disease-modifying therapy, has shown potential neuroprotective effects beyond relapse reduction, including preserva...

Area postrema syndrome and longitudinally extensive transverse myelitis masquerading as leptomeningeal carcinomatosis